Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...
Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
The process of separating useful molecules from mixtures of other substances accounts for 15% of the nation's energy, emits ...
Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...
Viral diseases remain a significant global health challenge, causing widespread morbidity and mortality. Advances in ...
Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...
Destiny 2’s pinnacle PVP activity, Trials of Osiris, returns yet again. If you want to know what this week’s featured map and weapon are, we have all that and more in this breakdown of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback